0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Mirtazapine Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-6Z8093
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Mirtazapine Market Insights and Forecast to 2028
BUY CHAPTERS

Global Mirtazapine Market Research Report 2025

Code: QYRE-Auto-6Z8093
Report
July 2025
Pages:107
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Mirtazapine Market

The global market for Mirtazapine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Mirtazapine ACTS on central presynaptic receptor 2 antagonist and enhances adrenergic nerve conduction.It regulates the function of 5-ht by interacting with central serotonin (5-ht2, 5-ht3) receptors.Both of mirtazapine"s optically active enantiomers have antidepressant activity, with the levorotatory block of type 2 receptor and 5-ht2 receptor, and the right-handed block of 5-ht3 receptor.Mirtazapine has sedative effects, is well tolerated, has almost no anticholinergic effects, and its therapeutic dose has no effect on the cardiovascular system.
North American market for Mirtazapine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Mirtazapine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Mirtazapine include Novartis, Organon, CIMA Labs.Inc., Merck & Co, Teva, Mylan, Sun Pharmaceutical, IMPAX, Aurobindo Pharma, Zydus Pharmaceuticals, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Mirtazapine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mirtazapine.
The Mirtazapine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Mirtazapine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mirtazapine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Mirtazapine Market Report

Report Metric Details
Report Name Mirtazapine Market
Segment by Type
  • 15 Mg Tablets
  • 30 Mg Tablets
  • 45 Mg Tablets
Segment by Application
  • Depression
  • Insomnia
  • Weight Loss
  • Mood Swings
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Novartis, Organon, CIMA Labs.Inc., Merck & Co, Teva, Mylan, Sun Pharmaceutical, IMPAX, Aurobindo Pharma, Zydus Pharmaceuticals, APOTEX, Harbin Sanlian Pharmaceutical, Shanxi Kangbao Biological Products, Huayu Pharmaceutical, Hangzhou Moshadong Pharmaceutical, Shanghai Xinyi Vientiane Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Mirtazapine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Mirtazapine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Mirtazapine Market report?

Ans: The main players in the Mirtazapine Market are Novartis, Organon, CIMA Labs.Inc., Merck & Co, Teva, Mylan, Sun Pharmaceutical, IMPAX, Aurobindo Pharma, Zydus Pharmaceuticals, APOTEX, Harbin Sanlian Pharmaceutical, Shanxi Kangbao Biological Products, Huayu Pharmaceutical, Hangzhou Moshadong Pharmaceutical, Shanghai Xinyi Vientiane Pharmaceutical

What are the Application segmentation covered in the Mirtazapine Market report?

Ans: The Applications covered in the Mirtazapine Market report are Depression, Insomnia, Weight Loss, Mood Swings, Other

What are the Type segmentation covered in the Mirtazapine Market report?

Ans: The Types covered in the Mirtazapine Market report are 15 Mg Tablets, 30 Mg Tablets, 45 Mg Tablets

1 Mirtazapine Market Overview
1.1 Product Definition
1.2 Mirtazapine by Type
1.2.1 Global Mirtazapine Market Value Comparison by Type (2024 VS 2031)
1.2.2 15 Mg Tablets
1.2.3 30 Mg Tablets
1.2.4 45 Mg Tablets
1.3 Mirtazapine by Application
1.3.1 Global Mirtazapine Market Value by Application (2024 VS 2031)
1.3.2 Depression
1.3.3 Insomnia
1.3.4 Weight Loss
1.3.5 Mood Swings
1.3.6 Other
1.4 Global Mirtazapine Market Size Estimates and Forecasts
1.4.1 Global Mirtazapine Revenue 2020-2031
1.4.2 Global Mirtazapine Sales 2020-2031
1.4.3 Global Mirtazapine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Mirtazapine Market Competition by Manufacturers
2.1 Global Mirtazapine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Mirtazapine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Mirtazapine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Mirtazapine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Mirtazapine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Mirtazapine, Product Type & Application
2.7 Global Key Manufacturers of Mirtazapine, Date of Enter into This Industry
2.8 Global Mirtazapine Market Competitive Situation and Trends
2.8.1 Global Mirtazapine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Mirtazapine Players Market Share by Revenue
2.8.3 Global Mirtazapine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Mirtazapine Market Scenario by Region
3.1 Global Mirtazapine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Mirtazapine Sales by Region: 2020-2031
3.2.1 Global Mirtazapine Sales by Region: 2020-2025
3.2.2 Global Mirtazapine Sales by Region: 2026-2031
3.3 Global Mirtazapine Revenue by Region: 2020-2031
3.3.1 Global Mirtazapine Revenue by Region: 2020-2025
3.3.2 Global Mirtazapine Revenue by Region: 2026-2031
3.4 North America Mirtazapine Market Facts & Figures by Country
3.4.1 North America Mirtazapine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Mirtazapine Sales by Country (2020-2031)
3.4.3 North America Mirtazapine Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Mirtazapine Market Facts & Figures by Country
3.5.1 Europe Mirtazapine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Mirtazapine Sales by Country (2020-2031)
3.5.3 Europe Mirtazapine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Mirtazapine Market Facts & Figures by Region
3.6.1 Asia Pacific Mirtazapine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Mirtazapine Sales by Region (2020-2031)
3.6.3 Asia Pacific Mirtazapine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Mirtazapine Market Facts & Figures by Country
3.7.1 Latin America Mirtazapine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Mirtazapine Sales by Country (2020-2031)
3.7.3 Latin America Mirtazapine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Mirtazapine Market Facts & Figures by Country
3.8.1 Middle East and Africa Mirtazapine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Mirtazapine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Mirtazapine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Mirtazapine Sales by Type (2020-2031)
4.1.1 Global Mirtazapine Sales by Type (2020-2025)
4.1.2 Global Mirtazapine Sales by Type (2026-2031)
4.1.3 Global Mirtazapine Sales Market Share by Type (2020-2031)
4.2 Global Mirtazapine Revenue by Type (2020-2031)
4.2.1 Global Mirtazapine Revenue by Type (2020-2025)
4.2.2 Global Mirtazapine Revenue by Type (2026-2031)
4.2.3 Global Mirtazapine Revenue Market Share by Type (2020-2031)
4.3 Global Mirtazapine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Mirtazapine Sales by Application (2020-2031)
5.1.1 Global Mirtazapine Sales by Application (2020-2025)
5.1.2 Global Mirtazapine Sales by Application (2026-2031)
5.1.3 Global Mirtazapine Sales Market Share by Application (2020-2031)
5.2 Global Mirtazapine Revenue by Application (2020-2031)
5.2.1 Global Mirtazapine Revenue by Application (2020-2025)
5.2.2 Global Mirtazapine Revenue by Application (2026-2031)
5.2.3 Global Mirtazapine Revenue Market Share by Application (2020-2031)
5.3 Global Mirtazapine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Company Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Mirtazapine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Novartis Mirtazapine Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 Organon
6.2.1 Organon Company Information
6.2.2 Organon Description and Business Overview
6.2.3 Organon Mirtazapine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Organon Mirtazapine Product Portfolio
6.2.5 Organon Recent Developments/Updates
6.3 CIMA Labs.Inc.
6.3.1 CIMA Labs.Inc. Company Information
6.3.2 CIMA Labs.Inc. Description and Business Overview
6.3.3 CIMA Labs.Inc. Mirtazapine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 CIMA Labs.Inc. Mirtazapine Product Portfolio
6.3.5 CIMA Labs.Inc. Recent Developments/Updates
6.4 Merck & Co
6.4.1 Merck & Co Company Information
6.4.2 Merck & Co Description and Business Overview
6.4.3 Merck & Co Mirtazapine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Merck & Co Mirtazapine Product Portfolio
6.4.5 Merck & Co Recent Developments/Updates
6.5 Teva
6.5.1 Teva Company Information
6.5.2 Teva Description and Business Overview
6.5.3 Teva Mirtazapine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Teva Mirtazapine Product Portfolio
6.5.5 Teva Recent Developments/Updates
6.6 Mylan
6.6.1 Mylan Company Information
6.6.2 Mylan Description and Business Overview
6.6.3 Mylan Mirtazapine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Mylan Mirtazapine Product Portfolio
6.6.5 Mylan Recent Developments/Updates
6.7 Sun Pharmaceutical
6.7.1 Sun Pharmaceutical Company Information
6.7.2 Sun Pharmaceutical Description and Business Overview
6.7.3 Sun Pharmaceutical Mirtazapine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Sun Pharmaceutical Mirtazapine Product Portfolio
6.7.5 Sun Pharmaceutical Recent Developments/Updates
6.8 IMPAX
6.8.1 IMPAX Company Information
6.8.2 IMPAX Description and Business Overview
6.8.3 IMPAX Mirtazapine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 IMPAX Mirtazapine Product Portfolio
6.8.5 IMPAX Recent Developments/Updates
6.9 Aurobindo Pharma
6.9.1 Aurobindo Pharma Company Information
6.9.2 Aurobindo Pharma Description and Business Overview
6.9.3 Aurobindo Pharma Mirtazapine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Aurobindo Pharma Mirtazapine Product Portfolio
6.9.5 Aurobindo Pharma Recent Developments/Updates
6.10 Zydus Pharmaceuticals
6.10.1 Zydus Pharmaceuticals Company Information
6.10.2 Zydus Pharmaceuticals Description and Business Overview
6.10.3 Zydus Pharmaceuticals Mirtazapine Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Zydus Pharmaceuticals Mirtazapine Product Portfolio
6.10.5 Zydus Pharmaceuticals Recent Developments/Updates
6.11 APOTEX
6.11.1 APOTEX Company Information
6.11.2 APOTEX Description and Business Overview
6.11.3 APOTEX Mirtazapine Sales, Revenue and Gross Margin (2020-2025)
6.11.4 APOTEX Mirtazapine Product Portfolio
6.11.5 APOTEX Recent Developments/Updates
6.12 Harbin Sanlian Pharmaceutical
6.12.1 Harbin Sanlian Pharmaceutical Company Information
6.12.2 Harbin Sanlian Pharmaceutical Description and Business Overview
6.12.3 Harbin Sanlian Pharmaceutical Mirtazapine Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Harbin Sanlian Pharmaceutical Mirtazapine Product Portfolio
6.12.5 Harbin Sanlian Pharmaceutical Recent Developments/Updates
6.13 Shanxi Kangbao Biological Products
6.13.1 Shanxi Kangbao Biological Products Company Information
6.13.2 Shanxi Kangbao Biological Products Description and Business Overview
6.13.3 Shanxi Kangbao Biological Products Mirtazapine Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Shanxi Kangbao Biological Products Mirtazapine Product Portfolio
6.13.5 Shanxi Kangbao Biological Products Recent Developments/Updates
6.14 Huayu Pharmaceutical
6.14.1 Huayu Pharmaceutical Company Information
6.14.2 Huayu Pharmaceutical Description and Business Overview
6.14.3 Huayu Pharmaceutical Mirtazapine Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Huayu Pharmaceutical Mirtazapine Product Portfolio
6.14.5 Huayu Pharmaceutical Recent Developments/Updates
6.15 Hangzhou Moshadong Pharmaceutical
6.15.1 Hangzhou Moshadong Pharmaceutical Company Information
6.15.2 Hangzhou Moshadong Pharmaceutical Description and Business Overview
6.15.3 Hangzhou Moshadong Pharmaceutical Mirtazapine Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Hangzhou Moshadong Pharmaceutical Mirtazapine Product Portfolio
6.15.5 Hangzhou Moshadong Pharmaceutical Recent Developments/Updates
6.16 Shanghai Xinyi Vientiane Pharmaceutical
6.16.1 Shanghai Xinyi Vientiane Pharmaceutical Company Information
6.16.2 Shanghai Xinyi Vientiane Pharmaceutical Description and Business Overview
6.16.3 Shanghai Xinyi Vientiane Pharmaceutical Mirtazapine Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Shanghai Xinyi Vientiane Pharmaceutical Mirtazapine Product Portfolio
6.16.5 Shanghai Xinyi Vientiane Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Mirtazapine Industry Chain Analysis
7.2 Mirtazapine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Mirtazapine Production Mode & Process Analysis
7.4 Mirtazapine Sales and Marketing
7.4.1 Mirtazapine Sales Channels
7.4.2 Mirtazapine Distributors
7.5 Mirtazapine Customer Analysis
8 Mirtazapine Market Dynamics
8.1 Mirtazapine Industry Trends
8.2 Mirtazapine Market Drivers
8.3 Mirtazapine Market Challenges
8.4 Mirtazapine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Mirtazapine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Mirtazapine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Mirtazapine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Mirtazapine Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Mirtazapine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Mirtazapine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Mirtazapine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Mirtazapine Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Mirtazapine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Mirtazapine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Mirtazapine, Product Type & Application
 Table 12. Global Key Manufacturers of Mirtazapine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Mirtazapine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mirtazapine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Mirtazapine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Mirtazapine Sales by Region (2020-2025) & (K Units)
 Table 18. Global Mirtazapine Sales Market Share by Region (2020-2025)
 Table 19. Global Mirtazapine Sales by Region (2026-2031) & (K Units)
 Table 20. Global Mirtazapine Sales Market Share by Region (2026-2031)
 Table 21. Global Mirtazapine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Mirtazapine Revenue Market Share by Region (2020-2025)
 Table 23. Global Mirtazapine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Mirtazapine Revenue Market Share by Region (2026-2031)
 Table 25. North America Mirtazapine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Mirtazapine Sales by Country (2020-2025) & (K Units)
 Table 27. North America Mirtazapine Sales by Country (2026-2031) & (K Units)
 Table 28. North America Mirtazapine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Mirtazapine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Mirtazapine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Mirtazapine Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Mirtazapine Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Mirtazapine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Mirtazapine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Mirtazapine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Mirtazapine Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Mirtazapine Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Mirtazapine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Mirtazapine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Mirtazapine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Mirtazapine Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Mirtazapine Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Mirtazapine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Mirtazapine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Mirtazapine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Mirtazapine Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Mirtazapine Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Mirtazapine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Mirtazapine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Mirtazapine Sales (K Units) by Type (2020-2025)
 Table 51. Global Mirtazapine Sales (K Units) by Type (2026-2031)
 Table 52. Global Mirtazapine Sales Market Share by Type (2020-2025)
 Table 53. Global Mirtazapine Sales Market Share by Type (2026-2031)
 Table 54. Global Mirtazapine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Mirtazapine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Mirtazapine Revenue Market Share by Type (2020-2025)
 Table 57. Global Mirtazapine Revenue Market Share by Type (2026-2031)
 Table 58. Global Mirtazapine Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Mirtazapine Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Mirtazapine Sales (K Units) by Application (2020-2025)
 Table 61. Global Mirtazapine Sales (K Units) by Application (2026-2031)
 Table 62. Global Mirtazapine Sales Market Share by Application (2020-2025)
 Table 63. Global Mirtazapine Sales Market Share by Application (2026-2031)
 Table 64. Global Mirtazapine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Mirtazapine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Mirtazapine Revenue Market Share by Application (2020-2025)
 Table 67. Global Mirtazapine Revenue Market Share by Application (2026-2031)
 Table 68. Global Mirtazapine Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Mirtazapine Price (US$/Unit) by Application (2026-2031)
 Table 70. Novartis Company Information
 Table 71. Novartis Description and Business Overview
 Table 72. Novartis Mirtazapine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Novartis Mirtazapine Product
 Table 74. Novartis Recent Developments/Updates
 Table 75. Organon Company Information
 Table 76. Organon Description and Business Overview
 Table 77. Organon Mirtazapine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Organon Mirtazapine Product
 Table 79. Organon Recent Developments/Updates
 Table 80. CIMA Labs.Inc. Company Information
 Table 81. CIMA Labs.Inc. Description and Business Overview
 Table 82. CIMA Labs.Inc. Mirtazapine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. CIMA Labs.Inc. Mirtazapine Product
 Table 84. CIMA Labs.Inc. Recent Developments/Updates
 Table 85. Merck & Co Company Information
 Table 86. Merck & Co Description and Business Overview
 Table 87. Merck & Co Mirtazapine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Merck & Co Mirtazapine Product
 Table 89. Merck & Co Recent Developments/Updates
 Table 90. Teva Company Information
 Table 91. Teva Description and Business Overview
 Table 92. Teva Mirtazapine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Teva Mirtazapine Product
 Table 94. Teva Recent Developments/Updates
 Table 95. Mylan Company Information
 Table 96. Mylan Description and Business Overview
 Table 97. Mylan Mirtazapine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Mylan Mirtazapine Product
 Table 99. Mylan Recent Developments/Updates
 Table 100. Sun Pharmaceutical Company Information
 Table 101. Sun Pharmaceutical Description and Business Overview
 Table 102. Sun Pharmaceutical Mirtazapine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Sun Pharmaceutical Mirtazapine Product
 Table 104. Sun Pharmaceutical Recent Developments/Updates
 Table 105. IMPAX Company Information
 Table 106. IMPAX Description and Business Overview
 Table 107. IMPAX Mirtazapine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. IMPAX Mirtazapine Product
 Table 109. IMPAX Recent Developments/Updates
 Table 110. Aurobindo Pharma Company Information
 Table 111. Aurobindo Pharma Description and Business Overview
 Table 112. Aurobindo Pharma Mirtazapine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Aurobindo Pharma Mirtazapine Product
 Table 114. Aurobindo Pharma Recent Developments/Updates
 Table 115. Zydus Pharmaceuticals Company Information
 Table 116. Zydus Pharmaceuticals Description and Business Overview
 Table 117. Zydus Pharmaceuticals Mirtazapine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Zydus Pharmaceuticals Mirtazapine Product
 Table 119. Zydus Pharmaceuticals Recent Developments/Updates
 Table 120. APOTEX Company Information
 Table 121. APOTEX Description and Business Overview
 Table 122. APOTEX Mirtazapine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. APOTEX Mirtazapine Product
 Table 124. APOTEX Recent Developments/Updates
 Table 125. Harbin Sanlian Pharmaceutical Company Information
 Table 126. Harbin Sanlian Pharmaceutical Description and Business Overview
 Table 127. Harbin Sanlian Pharmaceutical Mirtazapine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Harbin Sanlian Pharmaceutical Mirtazapine Product
 Table 129. Harbin Sanlian Pharmaceutical Recent Developments/Updates
 Table 130. Shanxi Kangbao Biological Products Company Information
 Table 131. Shanxi Kangbao Biological Products Description and Business Overview
 Table 132. Shanxi Kangbao Biological Products Mirtazapine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Shanxi Kangbao Biological Products Mirtazapine Product
 Table 134. Shanxi Kangbao Biological Products Recent Developments/Updates
 Table 135. Huayu Pharmaceutical Company Information
 Table 136. Huayu Pharmaceutical Description and Business Overview
 Table 137. Huayu Pharmaceutical Mirtazapine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Huayu Pharmaceutical Mirtazapine Product
 Table 139. Huayu Pharmaceutical Recent Developments/Updates
 Table 140. Hangzhou Moshadong Pharmaceutical Company Information
 Table 141. Hangzhou Moshadong Pharmaceutical Description and Business Overview
 Table 142. Hangzhou Moshadong Pharmaceutical Mirtazapine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Hangzhou Moshadong Pharmaceutical Mirtazapine Product
 Table 144. Hangzhou Moshadong Pharmaceutical Recent Developments/Updates
 Table 145. Shanghai Xinyi Vientiane Pharmaceutical Company Information
 Table 146. Shanghai Xinyi Vientiane Pharmaceutical Description and Business Overview
 Table 147. Shanghai Xinyi Vientiane Pharmaceutical Mirtazapine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. Shanghai Xinyi Vientiane Pharmaceutical Mirtazapine Product
 Table 149. Shanghai Xinyi Vientiane Pharmaceutical Recent Developments/Updates
 Table 150. Key Raw Materials Lists
 Table 151. Raw Materials Key Suppliers Lists
 Table 152. Mirtazapine Distributors List
 Table 153. Mirtazapine Customers List
 Table 154. Mirtazapine Market Trends
 Table 155. Mirtazapine Market Drivers
 Table 156. Mirtazapine Market Challenges
 Table 157. Mirtazapine Market Restraints
 Table 158. Research Programs/Design for This Report
 Table 159. Key Data Information from Secondary Sources
 Table 160. Key Data Information from Primary Sources
 Table 161. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Mirtazapine
 Figure 2. Global Mirtazapine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Mirtazapine Market Share by Type: 2024 & 2031
 Figure 4. 15 Mg Tablets Product Picture
 Figure 5. 30 Mg Tablets Product Picture
 Figure 6. 45 Mg Tablets Product Picture
 Figure 7. Global Mirtazapine Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Mirtazapine Market Share by Application: 2024 & 2031
 Figure 9. Depression
 Figure 10. Insomnia
 Figure 11. Weight Loss
 Figure 12. Mood Swings
 Figure 13. Other
 Figure 14. Global Mirtazapine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Mirtazapine Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Mirtazapine Sales (2020-2031) & (K Units)
 Figure 17. Global Mirtazapine Average Price (US$/Unit) & (2020-2031)
 Figure 18. Mirtazapine Report Years Considered
 Figure 19. Mirtazapine Sales Share by Manufacturers in 2024
 Figure 20. Global Mirtazapine Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest Mirtazapine Players: Market Share by Revenue in Mirtazapine in 2024
 Figure 22. Mirtazapine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global Mirtazapine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America Mirtazapine Sales Market Share by Country (2020-2031)
 Figure 25. North America Mirtazapine Revenue Market Share by Country (2020-2031)
 Figure 26. U.S. Mirtazapine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada Mirtazapine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe Mirtazapine Sales Market Share by Country (2020-2031)
 Figure 29. Europe Mirtazapine Revenue Market Share by Country (2020-2031)
 Figure 30. Germany Mirtazapine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France Mirtazapine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. Mirtazapine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy Mirtazapine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia Mirtazapine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific Mirtazapine Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific Mirtazapine Revenue Market Share by Region (2020-2031)
 Figure 37. China Mirtazapine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan Mirtazapine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea Mirtazapine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India Mirtazapine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia Mirtazapine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Taiwan Mirtazapine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Indonesia Mirtazapine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Thailand Mirtazapine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Malaysia Mirtazapine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Philippines Mirtazapine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Latin America Mirtazapine Sales Market Share by Country (2020-2031)
 Figure 48. Latin America Mirtazapine Revenue Market Share by Country (2020-2031)
 Figure 49. Mexico Mirtazapine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Brazil Mirtazapine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Argentina Mirtazapine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Middle East and Africa Mirtazapine Sales Market Share by Country (2020-2031)
 Figure 53. Middle East and Africa Mirtazapine Revenue Market Share by Country (2020-2031)
 Figure 54. Turkey Mirtazapine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Saudi Arabia Mirtazapine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. UAE Mirtazapine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Global Sales Market Share of Mirtazapine by Type (2020-2031)
 Figure 58. Global Revenue Market Share of Mirtazapine by Type (2020-2031)
 Figure 59. Global Mirtazapine Price (US$/Unit) by Type (2020-2031)
 Figure 60. Global Sales Market Share of Mirtazapine by Application (2020-2031)
 Figure 61. Global Revenue Market Share of Mirtazapine by Application (2020-2031)
 Figure 62. Global Mirtazapine Price (US$/Unit) by Application (2020-2031)
 Figure 63. Mirtazapine Value Chain
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools